XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets Measured On Recurring Basis
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2021:
  Fair Value Measurements at Reporting Date Using
TotalQuoted Prices in Active Markets for Identical Assets
(Level 1)
Significant other
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Derivative liabilities:
Derivative Instruments$776,623 $— $— $776,623 
Total derivative liabilities$776,623 $— $— $776,623 
Total assets and liabilities measured at fair value$776,623 $— $— $776,623 

    The derivative liabilities above are classified as other long-term liabilities in the December 31, 2021 consolidated balance sheet.

The following table presents the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2020: 
  Fair Value Measurements at Reporting Date Using
TotalQuoted Prices in Active Markets for Identical Assets
(Level 1)
Significant other
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Derivative liabilities:
Derivative Instruments$703,747 $— $— $703,747 
Total derivative liabilities$703,747 $— $— $703,747 
Total assets and liabilities measured at fair value$703,747 $— $— $703,747 
Fair Value Measurements Using Significant Unobservable Inputs
The following table presents the Company’s liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of each of the years ended December 31, 2021 and 2020: 
Fair Value Measurements Using
Significant Unobservable Inputs
(Level 3)
December 31, 2021December 31, 2020
Beginning Balance$703,747 $658,917 
Total (earnings) loss recognized in earnings72,876 44,830 
Ending Balance$776,623 $703,747 

Earnings and losses resulting from changes in the fair value of the derivative instruments above are recorded as a component of interest and other expense.